François Moisson cofounded Excelya in 2014 with Frédéric Paqueville and, together, they drive the Executive Committee. Imbued with the entrepreneurial spirit, François began his career in consulting to better understand every aspect of successfully running a company. There, he worked with Frédéric, who shared his vision of creating a company in which all team members would actively participate in its development. The health sector naturally called through its ability to touch the lives of so many. After a few years in business development, he left to create Excelya which is now 800-strong across Europe. Today, he defines Group strategy with Frédéric and ensures that Excelya’s original DNA – to care for its team members, clients and patients while delivering on its promise of excellence – is carried in each of its actions. He has a Master of Business Administration from IAE Paris La Sorbonne and an Engineering degree from Arts et Métiers Paristech.
Frédéric Paqueville cofounded Excelya in 2014. He now leads the group with François Moisson. Together, they are in charge of defining company strategy and the selection of new markets, offers and potential acquisitions. Before creating Excelya, Frédéric worked as Business Manager for a consulting firm. He left to create a company that would align with his desire to take good care of people while delivering outstanding business results. This was the genesis of Excelya. With François, they set out to produce a virtuous circle of people taken care of at work, their increased productivity and strengthened business. Since then, they have led Excelya from 2 to 800 employees, taking the company from a start-up to a European leader. He has a Master of Business Administration from IAE Paris La Sorbonne and an Engineering Degree from Arts et Métiers Paristech.
Alan Morgan joined as Chief Executive Officer of Excelya in 2020 and is based in Paris. He defines company strategy with our cofounders and steers the Executive Committee. He has held numerous leadership positions in contract research organizations across Europe for the last 30 years. Prior to his current role, he served as Chief Operating Officer at Quanticate in the United Kingdom and, most notably, as Global Group President of ICON Clinical Research Services. He has also held executive positions at Covance, MDS Inc. (now part of Syneos) and RPS (now PRA). He has led over 6000 people in 72 countries, repeatedly taking companies from small-scale to pan-European enterprises. He holds a Bachelor of Science from City University London and is a Fellow of the Chartered Certified Accountants.
Nathalie Doize has more than 30 years of experience in drug development working for both CROs and pharmaceutical companies. She oversees our operations and project delivery across Europe, ensuring excellence and the highest quality for our clients. Nathalie joins Excelya from Syneos Health, where she served as Vice President of Operations and was responsible for the operation and oversight of operational teams in Europe and Asia Pacific. Before that, she served in a variety of roles in increasing seniority, including department management for Mapi Group, inVentiv Health Clinical and i3 Research. She has a nursing and pediatric nursing degree from Paris Nanterre University.
Emmanuelle was named Chief People Officer at Excelya in 2021. She has over 20 years’ experience in international HR leadership roles. In her prior company, Tech40 procurement leader Ivalua, Emmanuelle accompanied the acceleration, transformation and growth of the company by attracting the best talents and nurturing team development across the EMEA region. She has deep experience in creating a strong culture of engagement, agility and customer focus through initiatives encompassing smooth change management and continued compliance. Before Ivalua, she served in a variety of roles in increasing seniority, including software companies Infovista and Axway as well as telecommunications company TCL Communication, previously Alcatel Mobile. She started her career in marketing at pharmaceutical giant GSK. She holds a bachelor’s degree from IGS-HR Management School and a master’s degree in International Human Resources from ENS/ENSAM.
Rudolph has served as Chief Financial Officer at Excelya since 2021. He defines group financial strategy and aims to help Excelya scale its business globally. Rudolph joined Excelya after more than 20 years leading finance organizations in the technology sector. His range of experience includes scaling-up mid-sized startups such as Groupe Allo-Media and Nibelis in a CFO capacity, as well as supporting the expansion and structuring in EMEA of large groups such as Dell Technologies. He has a Master in Finance and Marketing from INSEEC.
Peter serves as Chief Technology Officer at Excelya and is based in Germany. He has over 27 years experience in conducting clinical trials by leveraging the latest technology to obtain reliable results quickly. Before joining Excelya, Peter was VP of Operations and General Partner at PRA Health Sciences. He began his career in health as a Manager of Information Technology and Data Management before moving up the ranks to Managing Director of various regions in Europe at IMEREM (now part of PRA Health Sciences) and ReSearch Pharmaceutical Services. He has a degree in Mechanical Engineering and Informatics from the Grundig Academy Nuremberg.
David has been Commercial Director at Excelya since 2020. From 2014 to 2020, David served as Global Key Account Manager at IQVIA, where he built strong relationships at Pierre Fabre, Ipsen, Servier and Galderma and was responsible for driving revenue across all IQVIA offers and service lines. Additionally, he held the positions of Solution Sales Director and Sales Operations Director at IMS Health from 2005 to 2014. David is passionate about his clients and making sure they receive the best care. David received his Doctor of Pharmacy from Université Paris Descartes and a Master of Business Administration from HEC Paris.